Advancing Safe Medications for Moms and Babies Act of 2026

This legislation directs the Food and Drug Administration to update regulations requiring the inclusion of pregnant women in clinical trials for new medications. It also mandates the National Institutes of Health to prioritize research projects focused on the safety and efficacy of drugs prescribed to pregnant and lactating women. To support these changes, the bill authorizes funding for an education campaign that informs patients and healthcare providers about available research opportunities and registries. Finally, the act requires the relevant agencies to submit work plans and progress reports to Congress regarding these regulatory and research initiatives.